
浏览全部资源
扫码关注微信
纸质出版日期:2021,
扫 描 看 全 文
赵思琦, 刘栋梁, 夏毓琦, 等. 基于PMC指数模型的我国慢病管理政策量化评价[J]. 中国药房, 2021,32(13).
ZHAO Siqi, LIU Dongliang, XIA Yuqi, et al. Quantitative Evaluation of Chronic Disease Management Policy in China Based on PMC Index Model[J]. China Pharmacy, 2021,32(13).
目的:总结目前我国慢病管理政策的成绩与不足,为政策的制定和完善提供参考。方法:采用文本挖掘方法对2009-2020年国务院及各部委出台的109份慢病管理相关政策文件进行处理,建立慢病管理政策PMC指数评价模型,并通过10个一级指标和40个二级指标对16项典型慢病管理政策进行量化评价分析。结果:16项政策中,优秀级10项,可接受级6项,PMC指数得分均值为7.243分,总体处于可接受水平,但仍有较大改进空间。通过对比两项代表性的政策发现,其中一项得分较低的主要原因为缺乏长期发展规划、未涉及“互联网+慢病管理”新模式等内容、人才培养和法律保障等激励措施不到位。结论:我国慢病管理政策基本完善,可从政策时效、政策内容以及激励方式层面着手进一步完善。
OBJECTIVE:To su mmarize the achievements and shortcomings of chronic disease management policies in China , and to provide reference for the formulation and improvement of the policy. METHODS :Totally 109 documents related to chronic disease management issued by the State Council and various ministries and commissions from 2009 to 2020 were processed by text mining method. PMC index evaluation model of chronic disease management policy was established. Sixteen typical chronic disease management policies were quantitatively evaluated and analyzed by 10 first-level indicators and 40 second-level indicators. RESULTS:Among the 16 policies,10 were of excellent level and 6 were of acceptable level. The average PMC score was 7.243, which was generally acceptable level but still had large room for improvement. By comparing two representative policies ,it was found that the main reasons for the policies with low scores were the lack of long-term development planning ,the absence of “Internet + chronic disease management ”new model and other contents ,and the lack of talent incentive and legal guarantee measures. CONCLUSIONS :Chronic disease management policy has been improved ,and it can be further improved from the aspects of policy prescription ,policy content and incentive mode.
慢病管理政策PMC指数模型量化评价
Chronic disease management policyPMC index modelQuantitative evaluation
0
浏览量
13
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621